The round was led by Reach Capital, with participation from SilverArc Capital, Industry Ventures, and existing investors TQ Ventures and Calibrate Ventures. The round brings Manifold's total capital raised to $40 million and positions the company as the emerging category leader in vertical AI for life sciences. Manifold's platform is transforming how biopharma companies and medical centers accelerate workflows from target identification to clinical development, market access, and precision medicine in the clinic.

Manifold is the AI platform for life sciences, accelerating life-changing medicines to patients. Their products speed up workflows in areas from target identification and clinical development to market access and precision medicine in the clinic, while maintaining the governance life sciences requires. Global companies and premier research institutions use Manifold to operate faster and more effectively.